Bimode 10mg Tablet SR

Introduction

Bimode is a prescription medication that contains the active ingredient Gliclazide. It is available under the brand name Bimode. Gliclazide is classified as an oral antidiabetic drug and is primarily used to manage high blood sugar levels in patients with type 2 diabetes.

Uses

Bimode is prescribed to control blood sugar levels in patients diagnosed with type 2 diabetes. It is used alongside a healthy diet and regular exercise to help regulate blood glucose levels. This medication is not intended for the treatment of type 1 diabetes or diabetic ketoacidosis.

Dosage and Administration

The dosage of Bimode may vary depending on individual patient factors, such as age, medical history, and response to treatment. Follow the instructions provided by your healthcare professional regarding the dosage and administration of this medication.

Generally, the initial recommended dose for adults is 30 mg once daily, taken with breakfast. Your healthcare professional may adjust the dose based on your blood sugar levels and individual needs. Take the medication as prescribed and not exceed the recommended dose.

Bimode should be swallowed whole with a glass of water. Do not crush or chew the tablet, as it is designed to release the medication gradually over time.

Mechanism of Action

Gliclazide, the active ingredient in Bimode, belongs to a class of medications called sulfonylureas. It works by stimulating the release of insulin from the beta cells in the pancreas. Insulin is a hormone that helps regulate blood sugar levels by facilitating the uptake of glucose from the bloodstream into the cells.

By increasing insulin production and improving the body’s response to insulin, Gliclazide helps lower blood sugar levels in patients with type 2 diabetes.

Side Effects

Common side effects may include:

• Hypoglycemia (low blood sugar): This can cause symptoms such as dizziness, sweating, confusion, and weakness. Monitor your blood sugar levels regularly and seek medical attention if you experience these symptoms.
• Gastrointestinal disturbances: These may include nausea, vomiting, diarrhea, or stomach discomfort.
• Skin reactions: In rare cases, some patients may experience skin rashes or itching.

Serious side effects of Bimode are rare but can occur. If you experience any of the following, seek immediate medical attention:

• Severe allergic reactions, such as swelling of the face, lips, tongue, or throat, or difficulty breathing.
• Signs of liver problems, such as yellowing of the skin or eyes, dark urine, or persistent abdominal pain.

Remember, this is not an exhaustive list of side effects. Consult your healthcare professional for more information and guidance.

Drug Interactions

Bimode may interact with certain medications and substances. Inform your healthcare professional about all the medications you are currently taking, including prescription drugs, over-the-counter medications, and herbal supplements.

Some common and serious drug interactions with Bimode include:

• Anticoagulant medications: Gliclazide may potentiate the effects of anticoagulant medications, increasing the risk of bleeding. Close monitoring and dosage adjustments may be necessary.
• Certain antibiotics: Some antibiotics, such as clarithromycin and erythromycin, may increase the concentration of Gliclazide in the blood. This can increase the risk of hypoglycemia. Your healthcare professional may need to adjust your dose.
• Alcohol: Alcohol consumption can increase the risk of hypoglycemia when taken with Bimode. It is advisable to limit or avoid alcohol while using this medication.

Discuss all potential drug interactions with your healthcare professional to ensure safe and effective use of Bimode.

Precautions

Before starting treatment with Bimode, inform your healthcare professional about any medical conditions or allergies you may have. This medication may not be suitable for everyone, and precautions should be taken in certain situations, including:

• Hypoglycemia: Bimode can lower blood sugar levels. Monitor your blood sugar regularly, especially if you are at higher risk of hypoglycemia, such as the elderly or those with impaired liver or kidney function.
• Liver or kidney problems: Bimode should be used with caution in patients with liver or kidney problems, as it may affect the metabolism and elimination of the medication.
• Pregnancy and breastfeeding: The safety of Bimode during pregnancy and breastfeeding has not been established. Consult your healthcare professional for guidance if you are pregnant, planning to become pregnant, or breastfeeding.

Follow all precautions and instructions provided by your healthcare professional to ensure safe and effective use of this medication.

Storage

Bimode should be stored at room temperature, away from excessive heat, moisture, and direct sunlight. Keep the medication out of reach of children and pets. Do not use this medication if it has expired or if the packaging is damaged.

Patient Tips

• Take the medication as prescribed by your healthcare professional. Do not skip doses or change the dosage without consulting your healthcare professional.
• Monitor your blood sugar levels regularly as advised by your healthcare professional.
• Follow a healthy diet and exercise regimen as recommended by your healthcare professional to support blood sugar control.
• Carry a source of fast-acting sugar, such as glucose tablets or candy, in case of hypoglycemia episodes.
• Keep a record of your blood sugar levels, medication doses, and any symptoms or side effects you experience. This information can be helpful during discussions with your healthcare professional.

Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.

References

• Gliclazide: a medicine to treat type 2 diabetes (NHS UK) [Accessed 10 Jun. 2024] (online) Available at:
• Dacadis MR 30mg Modified Release Tablets (Health Professionals SmPC) Available at:
• Gliclazide (International database) (Drugs.com) [Accessed 30 Jun. 2024] (online) Available at:
• Oral hypoglycemics overdose (MedlinePlus) [Accessed 9 Jun. 2024] (online) Available at:
• Tomlinson B, Li YH, Chan P. Evaluating gliclazide for the treatment of type 2 diabetes mellitus. Expert Opin Pharmacother. 2022 Dec;23(17):1869-1877. doi: 10.1080/14656566.2022.2141108. Epub 2022 Nov 10. [Accessed 21 Jun. 2024] Available at: